Polmacoxib
Specifications
1427301-99-2CAS Number
4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl]benzenesulfonamideIUPAC Name
C18H16FNO4SChemical Formula
361.4 g/molMolecular Weight
Polmacoxib; 301692-76-2; CG100649; CG-100649; IJ34D6YPAO; 4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl]benzenesulfonamide; DTXSID901029389; 4-(3-(3-Fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)-benzenesulfonamide; Benzenesulfonamide, 4-(3-(3-fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl)-; polmacoxibum; 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl)benzenesulfonamide; 4-[3-(3-Fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl]-benzenesulfonamide; RefChem:863919; M01AH07; DTXCID401514652; 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzene-1-sulfonamide; 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide; acelex; 4-[3-(3-Fluorophenyl)-5,5-Dimethyl-4-Oxidanylidene-Furan-2-Yl]benzenesulfonamide; Polmacoxib [USAN:INN]; UNII-IJ34D6YPAO; Polmacoxib [USAN]; Acelex (S. Korea); Polmacoxib (Standard); CG 100649; POLMACOXIB [INN]; Polmacoxib (USAN/INN); POLMACOXIB [WHO-DD]; CHEMBL166863; GTPL8316; orb1306413; SCHEMBL3233093; SCHEMBL29351757; EX-A601; IJWPAFMIFNSIGD-UHFFFAOYSA-N; GLXC-15832; 4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-2-furyl]benzenesulfonamide; BDBM50474760; HY-16726R; AKOS025149767; DB12399; SB17177; DA-42861; FP172578; HY-16726; MS-25723; CS-0012326; NS00068325; D10656; T21294; Q19598695; 5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone; 1427301-99-2; Polmacoxib; Benzenesulfonamide, 4-[3-(3-fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl]-; 4-[3-(3-Fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl]benzenesulfonamide; Acelex; CG 100649; PolmacoxibSynonyms
